Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02381626 · ClinicalTrials.gov registry record · NA
DRIIVE (Data and Research on Interventions to Improve the Vehicular Environment)
A NA study of Vehicular Environment, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
- 1
- Study location
NCT02381626: Completed NA study of Vehicular Environment, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02381626 is a NA study of Vehicular Environment that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02381626, a NA study of Vehicular Environment, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to look at air quality in cabs and see if the air quality inside taxi cabs is connected to increased risks for lung and heart health problems. Another purpose of the study is to see if putting an air filter inside the car may help improve the air quality and lower health risks. This is important because air pollution can be harmful to health. Air pollution is made up of very tiny particles (things) floating in the air around us, called particulate matter. Particulate matter is made up of dust, smoke, dirt, and gas fumes and can get into our bodies as we breathe. It has been linked to risk for lung cancer and heart disease. It is important because taxi drivers spend many hours of their day inside their cars. The investigators hope that this study will help them find out if using air filters inside cabs will help lower the levels of pollution in cabs and reduce its effects on the health of taxi drivers. They will use these results to educate the taxi driver community.
Primary Outcome
monitor/report the PM levels as time-averaged sample (hourly averages) that will be monitored at work site and at homes across all groups
Conditions Studied
Interventions
- BEHAVIORAL questionnaires
- OTHER Urine sample
- DEVICE HEPA air purifier
- OTHER Log-book
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2014-12 |
| Est. Completion | 2020-10-18 |
| Phase | NA |
What the finished NCT02381626 record still lists
NCT02381626 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Vehicular Environment appearing as the primary indexed condition, and to 4 interventions - of which questionnaires is the first listed.
NCT02381626 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02381626 about?
NCT02381626 is a clinical study titled "DRIIVE (Data and Research on Interventions to Improve the Vehicular Environment)". The purpose of this study is to look at air quality in cabs and see if the air quality inside taxi cabs is connected to increased risks for lung and heart health problems. Another purpose of the study is to see if putting an air filter inside the car may help improve the air quality and lower health...
What is the current status of trial NCT02381626?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2014-12. Estimated completion is 2020-10-18.
What conditions does trial NCT02381626 study?
This clinical trial studies the following conditions: Vehicular Environment.
What interventions are being tested in trial NCT02381626?
The interventions under investigation include: questionnaires (BEHAVIORAL), Urine sample (OTHER), HEPA air purifier (DEVICE), Log-book (OTHER).
Who is sponsoring clinical trial NCT02381626?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02381626 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02381626's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia